Macrotech Developers Shares Rise Over 4% As Lodha Brothers Settle Trademark Dispute

The shares of Macrotech Developers Ltd. rose over 4% on Tuesday after the Lodha brothers settled their trademark dispute under the guidance of their parents.

According to the terms of the resolution, the Abhishek Lodha-led Macrotech Developers will hold the exclusive rights to the surname brand 'Lodha' and 'Lodha Group'. Meanwhile, Abhinandan Lodha will hold the rights to the 'House of Abhinandan Lodha,' as per the media releases from their respective teams.

The media release circulated by their respective teams further mentioned that both Macrotech and House of Abhinandan Lodha will continue to be deemed as completely different entities with no connection whatsoever.

On Jan. 31, Abhishek and Abhinandan Lodha agreed to mediation over a trademark dispute concerning the 'Lodha' surname. The case was being heard by Justice Arif Doctor in the Bombay High Court. Macrotech Developers, led by Abhishek Lodha, sought to restrain Abhinandan’s company—House of Abhinandan Lodha—from using the 'Lodha' brand, also demanding Rs 5,000 crore in damages.

According to a 2015–2017 family agreement, Abhishek was to manage the Lodha Group real estate business, while Abhinandan would handle a separate venture. A new 2023 agreement, cited in court filings, explicitly barred Abhinandan’s business from using any version of the 'Lodha' name.

Macrotech alleged that HoABL violated this by continuing to use names like 'Lodha Ventures' and related domains. Although mediation began post the January hearing, tensions escalated when Macrotech accused HoABL of fraud and forgery—allegations which HoABL has strongly denied.

The shares of Macrotech Developers rose as much as 4.40% to Rs 1,169 apiece, the highest level since April 4. It pared gains to trade 2.72% higher at Rs 1,153.80 apiece, as of 9:25 a.m. This compares to a 2% advance in the NSE Nifty 50 Index.

It has fallen 3.43% in the last 12 months and 16.94% year-to-date. Total traded volume so far in the day stood at 1.5 times its 30-day average. The relative strength index was at 56.

Out of 18 analysts tracking the company, 14 maintain a 'buy' rating, three recommend a 'hold,' and one suggests 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 21.5%.